Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre study.
Fiche publication
Date publication
janvier 2021
Journal
Breast cancer research : BCR
Auteurs
Membres identifiés du Cancéropôle Est :
Dr LADOIRE Sylvain, Dr DESMOULINS Isabelle
Tous les auteurs :
Alhenc-Gelas M, Cabel L, Berger F, Delaloge S, Frenel JS, Levy C, Firmin N, Ladoire S, Desmoulins I, Heudel PE, Dalenc F, Loirat D, Dubot C, Vuagnat P, Deluche E, Mokdad-Adi M, Patsouris A, Annic J, Djerroudi L, Lavigne M, Pierga JY, Coppo P, Bidard FC
Lien Pubmed
Résumé
Cancer-related microangiopathic haemolytic anaemia (MAHA) is a rare but life-threatening paraneoplastic syndrome. Only single cases or small series have been reported to date. We set up a retrospective multicentre study focusing on breast cancer-related MAHA.
Mots clés
Breast cancer, Microangiopathic haemolytic anaemia, Prognostic factors, Survival
Référence
Breast Cancer Res. 2021 Jan 19;23(1):9